Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Thoracic Surgery ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Cancer Statistics Center.(Available at:) (Accessed June 6, 2022)
- Observation-only management of early stage, medically inoperable lung cancer: poor outcome.Chest. 2002; 121: 1155-1158
- Executive Summary: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.Chest. 2013; 143: 7S-37S
- Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.Ann Thorac Surg. 1995; 60: 615-623
- Wedge resection versus segmentectomy in patients with stage I non-small-cell lung cancer unfit for lobectomy. Japanese journal of clinical oncology.(Available at:) (Published December 27, 2019. Accessed July 19, 2022)
- Comparison of cancer control between segmentectomy and wedge resection in patients with clinical stage IA non–small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery.(Available at:) (Published October 22, 2020. Accessed July 19, 2022)
- A Multicenter Study of Complex Segmentectomy Versus Wedge Resection in Clinical Stage 0-IA Non-Small Cell Lung Cancer.Clin Lung Cancer. 2022; 23: 393-401
- Margin and local recurrence after sublobar resection of non-small cell lung cancer.Ann Surg Oncol. 2007; 14: 2400-2405
- Cytologically malignant margins of wedge resected stage I non-small cell lung cancer.Ann Thorac Surg. 2002; 74: 1953-1957
- Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer.Ann Thorac Surg. 2007; 84: 926-933
- Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.Lancet Oncol. 2019; 20: 494-503
- Radiobiology of stereotactic body radiation therapy (SBRT).Rep Pract Oncol Radiother. 2017; 22: 86-95
- Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study.Cancer. 2004; 101: 1623-1631
- Lung cancer specialists' opinions on treatment for stage I non-small cell lung cancer: A multidisciplinary survey.Adv Radiat Oncol. 2018; 3: 125-129
- Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.JAMA Oncol. 2019; 5: 681-688
- Stereotactic Body Radiotherapy Versus Delayed Surgery for Early-stage Non-small-cell Lung Cancer.Ann Surg. 2020; 272: 925-929
- Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.Lancet Oncol. 2015; 16 ([published correction appears in Lancet Oncol. 2015 Sep;16(9):e427]): 630-637
- Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy Trial (VALOR). ClinicalTrials.gov identifier: NCT02984761.(Available at:) (Updated March 21, 2022. Accessed July 19, 2022)
- A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC).Ann Surg Oncol. 2022; 29: 4686-4687
- Predictors of Chest Wall Toxicity after Lung Stereotactic Ablative Radiotherapy.Clin Oncol. 2016; 28: 28-35
- A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy.Int J Radiat Oncol Biol Phys. 2012; 82: 457-462
- Thermal ablation of stage I non-small cell lung carcinoma.Semin Intervent Radiol. 2014; 31: 118-124
- Radiofrequency ablation of lung metastases: factors influencing success.Eur Radiol. 2008; 18: 672-677
- Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial.Cancer. 2015; 121: 3491-3498
- Radiofrequency ablation vs. stereotactic body radiotherapy for stage IA non-small cell lung cancer in nonsurgical patients.J Cancer. 2021; 12: 3057-3066
- Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study).Lancet Oncol. 2008; 9: 621-628
- Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial.Gut. 2017; 66: 1172-1173
- Microwave ablation treatment for medically inoperable stage I non-small cell lung cancers: long-term results.Eur Radiol. 2022; 32: 5616-5622
- Mechanisms of tissue destruction following cryosurgery.Ann R Coll Surg Engl. 1984; 66: 313-318
- Percutaneous cryoablation of lung tumors: feasibility and safety.J Vasc Interv Radiol. 2012; 23: 295-305
- Five-year survival after cryoablation of stage I non-small cell lung cancer in medically inoperable patients.J Vasc Interv Radiol. 2015; 26: 312-319
- Microwave ablation vs. cryoablation for treatment of primary and metastatic pulmonary malignant tumors.Mol Clin Oncol. 2022; 16: 62
- Transbronchial Microwave Ablation – Important Role in the Battle of Lung Preservation for Multifocal Lung Primaries or Metastases.Ann Oncol. April. 2022; 33: S76-S77
- Endobronchial ultrasound-guided bipolar radiofrequency ablation for lung cancer: A first-in-human clinical trial [published online ahead of print, 2022 Mar 26].J Thorac Cardiovasc Surg. 2022; S0022-5223: 00344-350
- Transbronchial microwave ablation of lung nodules with electromagnetic navigation bronchoscopy guidance-a novel technique and initial experience with 30 cases.Transl Lung Cancer Res. 2021; 10: 1608-1622
- Late breaking abstract - bronchoscopic microwave ablation of peripheral lung tumors. European Respiratory Society.(Available at:) (Published September 5, 2021)
- Transbronchial Ablation for Peripheral Lung Tumor. ClinicalTrials.gov identifier: NCT02972177.(Available at:) (Updated February 18,2020. Accessed July 2, 2022)
- Comparison of the Efficacy of Stereotactic Body Radiotherapy versus Surgical Treatment for Early-Stage Non-Small Cell Lung Cancer after Propensity Score Matching.Transl Oncol. 2019; 12: 1032-1037
- Video-assisted thoracic lobectomy versus stereotactic body radiotherapy for stage I nonsmall cell lung cancer in elderly patients: a propensity matched comparative analysis.Eur Respir J. 2019; 53: 1801561
- Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer.J Thorac Cardiovasc Surg. 2018; 155: 395-402
- Outcomes of stereotactic body radiotherapy versus lobectomy for stage I non-small cell lung cancer: a propensity score matching analysis.BMC Pulm Med. 2019; 19: 98
- Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer.Ann Thorac Surg. 2015; 99: 1122-1129
- Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates.J Thorac Cardiovasc Surg. 2006; 131: 1007-1013
- Percutaneous cryoablation for the treatment of medically inoperable stage I non-small cell lung cancer.PLoS One. 2012; 7: e33223
- Microwave Ablation for Lung Neoplasms: A Retrospective Analysis of Long-Term Results.J Vasc Interv Radiol. 2017; 28: 206-211
- Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases.J Surg Oncol. 2014; 110: 758-763
- Radiofrequency ablation of stage IA non-small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial.J Cardiothorac Surg. 2018; 13: 91
- Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.Radiology. 2007; 243: 268-275
Article info
Publication history
Published online: February 26, 2023
Publication stage
In Press Corrected ProofIdentification
Copyright
© 2023 Elsevier Inc. All rights reserved.
